483 Patheon Pharmaceuticals Feb 2019

483 Patheon Pharmaceuticals Feb 2019

Jon Antoniou FDA, Lindsey Schwierjohann FDA, Ying Zhang FDA, Lindsey Fleischman FDA$119.00 - Available Now

FDA investigators audited the Patheon Pharmaceuticals - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 15 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Feb 2019
  • Location: Cincinnati, United States
  • FEI: 1510437
Add To Cart